Literature DB >> 25877502

Development of a Draft Core Set of Domains for Measuring Shared Decision Making in Osteoarthritis: An OMERACT Working Group on Shared Decision Making.

Karine Toupin-April1, Jennifer Barton1, Liana Fraenkel1, Linda Li1, Viviane Grandpierre1, Francis Guillemin1, Tamara Rader1, Dawn Stacey1, France Légaré1, Janet Jull1, Jennifer Petkovic1, Marieke Scholte-Voshaar1, Vivian Welch1, Anne Lyddiatt1, Cathie Hofstetter1, Maarten De Wit1, Lyn March1, Tanya Meade1, Robin Christensen1, Cécile Gaujoux-Viala1, Maria E Suarez-Almazor1, Annelies Boonen1, Christoph Pohl1, Richard Martin1, Peter S Tugwell1.   

Abstract

OBJECTIVE: Despite the importance of shared decision making for delivering patient-centered care in rheumatology, there is no consensus on how to measure its process and outcomes. The aim of this Outcome Measures in Rheumatology (OMERACT) working group is to determine the core set of domains for measuring shared decision making in intervention studies in adults with osteoarthritis (OA), from the perspectives of patients, health professionals, and researchers.
METHODS: We followed the OMERACT Filter 2.0 method to develop a draft core domain set by (1) forming an OMERACT working group; (2) conducting a review of domains of shared decision making; and (3) obtaining opinions of all those involved using a modified nominal group process held at a session activity at the OMERACT 12 meeting.
RESULTS: In all, 26 people from Europe, North America, and Australia, including 5 patient research partners, participated in the session activity. Participants identified the following domains for measuring shared decision making to be included as part of the draft core set: (1) identifying the decision, (2) exchanging information, (3) clarifying views, (4) deliberating, (5) making the decision, (6) putting the decision into practice, and (7) assessing the effect of the decision. Contextual factors were also suggested.
CONCLUSION: We proposed a draft core set of shared decision-making domains for OA intervention research studies. Next steps include a workshop at OMERACT 13 to reach consensus on these proposed domains in the wider OMERACT group, as well as to detail subdomains and assess instruments to develop a core outcome measurement set.

Entities:  

Keywords:  IMPLEMENTATION; OMERACT; OSTEOARTHRITIS; OUTCOME ASSESSMENT; OUTCOMES; SHARED DECISION MAKING

Mesh:

Year:  2015        PMID: 25877502      PMCID: PMC4607553          DOI: 10.3899/jrheum.141205

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  22 in total

1.  Decision making in analyses of women's birth stories.

Authors:  L Vandevusse
Journal:  Birth       Date:  1999-03       Impact factor: 3.689

Review 2.  Promoting informed decisions about cancer screening in communities and healthcare systems.

Authors:  Peter Briss; Barbara Rimer; Barbara Reilley; Ralph C Coates; Nancy C Lee; Patricia Mullen; Phaedra Corso; Angela B Hutchinson; Robert Hiatt; Jon Kerner; Prethibha George; Cornelia White; Nisha Gandhi; Mona Saraiya; Rosalind Breslow; George Isham; Steven M Teutsch; Alan R Hinman; Robert Lawrence
Journal:  Am J Prev Med       Date:  2004-01       Impact factor: 5.043

Review 3.  American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee.

Authors:  Marc C Hochberg; Roy D Altman; Karine Toupin April; Maria Benkhalti; Gordon Guyatt; Jessie McGowan; Tanveer Towheed; Vivian Welch; George Wells; Peter Tugwell
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-04       Impact factor: 4.794

4.  A systematic process for creating and appraising clinical vignettes to illustrate interprofessional shared decision making.

Authors:  Dawn Stacey; Nathalie Brière; Hubert Robitaille; Kimberly Fraser; Sophie Desroches; France Légaré
Journal:  J Interprof Care       Date:  2014-04-28       Impact factor: 2.338

Review 5.  Stop the silent misdiagnosis: patients' preferences matter.

Authors:  Albert G Mulley; Chris Trimble; Glyn Elwyn
Journal:  BMJ       Date:  2012-11-08

Review 6.  Twelve myths about shared decision making.

Authors:  France Légaré; Philippe Thompson-Leduc
Journal:  Patient Educ Couns       Date:  2014-07-03

7.  Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.

Authors:  Maarten Boers; John R Kirwan; George Wells; Dorcas Beaton; Laure Gossec; Maria-Antonietta d'Agostino; Philip G Conaghan; Clifton O Bingham; Peter Brooks; Robert Landewé; Lyn March; Lee S Simon; Jasvinder A Singh; Vibeke Strand; Peter Tugwell
Journal:  J Clin Epidemiol       Date:  2014-02-28       Impact factor: 6.437

Review 8.  Decision aids for people facing health treatment or screening decisions.

Authors:  Dawn Stacey; France Légaré; Nananda F Col; Carol L Bennett; Michael J Barry; Karen B Eden; Margaret Holmes-Rovner; Hilary Llewellyn-Thomas; Anne Lyddiatt; Richard Thomson; Lyndal Trevena; Julie H C Wu
Journal:  Cochrane Database Syst Rev       Date:  2014-01-28

9.  Shared decision making does not influence physicians against clinical practice guidelines.

Authors:  Mireille Guerrier; France Légaré; Stéphane Turcotte; Michel Labrecque; Louis-Paul Rivest
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

10.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update.

Authors:  Josef S Smolen; Robert Landewé; Ferdinand C Breedveld; Maya Buch; Gerd Burmester; Maxime Dougados; Paul Emery; Cécile Gaujoux-Viala; Laure Gossec; Jackie Nam; Sofia Ramiro; Kevin Winthrop; Maarten de Wit; Daniel Aletaha; Neil Betteridge; Johannes W J Bijlsma; Maarten Boers; Frank Buttgereit; Bernard Combe; Maurizio Cutolo; Nemanja Damjanov; Johanna M W Hazes; Marios Kouloumas; Tore K Kvien; Xavier Mariette; Karel Pavelka; Piet L C M van Riel; Andrea Rubbert-Roth; Marieke Scholte-Voshaar; David L Scott; Tuulikki Sokka-Isler; John B Wong; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2013-10-25       Impact factor: 19.103

View more
  9 in total

Review 1.  Incorporating the patient's perspective in outcomes research.

Authors:  Betty Hsiao; Liana Fraenkel
Journal:  Curr Opin Rheumatol       Date:  2017-03       Impact factor: 5.006

2.  [Shared decision making even for complex systemic autoimmune diseases such as Systemic Lupus Erythematosus (SLE)?]

Authors:  M Schneider; H Carnarius; T Schlegl
Journal:  Z Rheumatol       Date:  2017-04       Impact factor: 1.372

3.  Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group.

Authors:  Jennifer Petkovic; Jennifer L Barton; Caroline Flurey; Niti Goel; Christie M Bartels; Cheryl Barnabe; Maarten P T de Wit; Anne Lyddiatt; Diane Lacaille; Vivian Welch; Annelies Boonen; Beverley Shea; Robin Christensen; Lara J Maxwell; Willemina Campbell; Janet Jull; Karine Toupin-April; Jasvinder A Singh; Charles H Goldsmith; Antoine G Sreih; Christoph Pohl; Catherine Hofstetter; Dorcas E Beaton; Rachelle Buchbinder; Francis Guillemin; Peter S Tugwell
Journal:  J Rheumatol       Date:  2017-02-15       Impact factor: 4.666

4.  OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions.

Authors:  Karine Toupin-April; Jennifer L Barton; Liana Fraenkel; Alexa Meara; Linda C Li; Peter Brooks; Maarten de Wit; Dawn Stacey; France Légaré; Beverley Shea; Anne Lyddiatt; Cathie Hofstetter; Robin Christensen; Marieke Scholte Voshaar; Maria E Suarez-Almazor; Annelies Boonen; Tanya Meade; Lyn March; Janet Elizabeth Jull; Willemina Campbell; Rieke Alten; Suvi Karuranga; Esi M Morgan; Ayano Kelly; Jessica Kaufman; Sophie Hill; Lara J Maxwell; Dorcas Beaton; Yasser El-Miedany; Shikha Mittoo; Susan J Bartlett; Jasvinder A Singh; Peter S Tugwell
Journal:  J Rheumatol       Date:  2019-02-01       Impact factor: 4.666

5.  Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting.

Authors:  Karine Toupin-April; Jennifer Barton; Liana Fraenkel; Linda C Li; Peter Brooks; Maarten De Wit; Dawn Stacey; France Légaré; Alexa Meara; Beverley Shea; Anne Lyddiatt; Cathie Hofstetter; Laure Gossec; Robin Christensen; Marieke Scholte-Voshaar; Maria E Suarez-Almazor; Annelies Boonen; Tanya Meade; Lyn March; Christoph Pohl; Janet Elizabeth Jull; Sigogini Sivarajah; Willemina Campbell; Rieke Alten; Suvi Karuranga; Esi Morgan; Jessica Kaufman; Sophie Hill; Lara J Maxwell; Vivian Welch; Dorcas Beaton; Yasser El-Miedany; Peter S Tugwell
Journal:  J Rheumatol       Date:  2017-08-01       Impact factor: 4.666

6.  Patient Preference Studies During Early Drug Development: Aligning Stakeholders to Ensure Development Plans Meet Patient Needs.

Authors:  Nigel S Cook; Julie Cave; Anke-Peggy Holtorf
Journal:  Front Med (Lausanne)       Date:  2019-04-24

Review 7.  Lifestyle Medicine for Chronic Lower Back Pain: An Evidence-Based Approach.

Authors:  Ziya Altug
Journal:  Am J Lifestyle Med       Date:  2021-07-21

Review 8.  New galaxies in the universe of shared decision-making and rheumatoid arthritis.

Authors:  Jennifer L Barton; Simon Décary
Journal:  Curr Opin Rheumatol       Date:  2020-05       Impact factor: 4.941

9.  Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.

Authors:  Ayano Kelly; Allison Tong; Kathleen Tymms; Lyn March; Jonathan C Craig; Mary De Vera; Vicki Evans; Geraldine Hassett; Karine Toupin-April; Bart van den Bemt; Armando Teixeira-Pinto; Rieke Alten; Susan J Bartlett; Willemina Campbell; Therese Dawson; Michael Gill; Renske Hebing; Alexa Meara; Robby Nieuwlaat; Yomei Shaw; Jasvinder A Singh; Maria Suarez-Almazor; Daniel Sumpton; Peter Wong; Robin Christensen; Dorcas Beaton; Maarten de Wit; Peter Tugwell
Journal:  Trials       Date:  2018-03-27       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.